Bavarian Nordic A/S Announces Completion of Directed Issue of 7,046,839 New Ordinary Shares
Click here for more information
Published on February 20, 2023, 22:40 CET
- About us
- What we do
From R&D to manufacturing
We are focused on the research, development and manufacturing of innovative life-saving vaccines
READ MORE - INVESTORS
Investors
We are committed to providing our shareholders and the media with reliable and transparent information about our business, development programs and results in an open and timely manner
Read more - Careers
Careers
We offer a challenging international working environment in which job satisfaction and personal growth have a high priority.
READ MORE